Cite
HARVARD Citation
Duchnowska, R. et al. (2013). Correlation Between Quantitative HER‐2 Protein Expression and Risk for Brain Metastases in HER‐2+ Advanced Breast Cancer Patients Receiving Trastuzumab‐Containing Therapy. Oncologist. p. 775. [Online].